Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Covance
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
45.0%
-2.5% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Labcorp Drug Development
Competitor Displacement Rate
25.0%
Competitors are displacing Covance in 25.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Covance appears to be losing ground to Labcorp, potentially due to Labcorp's broader service offerings and stronger market presence in early-stage research and development. This suggests a need to strengthen integrated service capabilities.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[labcorp.com][iqvia.com]⚠️ Identified Vulnerability:Integrated Services
Primary Threat Identified:Labcorp Drug Development
Target Persona:Clinical Trial Managers
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)